LRRK2

LRRK2 Overview

English NameLeucine-rich repeat serine/threonine-protein kinase 2Approved Drugs0
Drugs in Clinical Trials11Target SynonymPARK8,LRRK2,Leucine Rich Repeat Kinase 2,Leucine-Rich Repeat Serine/Threonine-Protein Kinase 2,Parkinson Disease (Autosomal Dominant) 8,Augmented In Rheumatoid Arthritis 17,Dardarin,AURA17,RIPK7,ROCO2,Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,DKFZp434H2111,FLJ45829
Highest Development StagePhase 2 Clinical
English NameLeucine-rich repeat serine/threonine-protein kinase 2
Target SynonymPARK8,LRRK2,Leucine Rich Repeat Kinase 2,Leucine-Rich Repeat Serine/Threonine-Protein Kinase 2,Parkinson Disease (Autosomal Dominant) 8,Augmented In Rheumatoid Arthritis 17,Dardarin,AURA17,RIPK7,ROCO2,Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,DKFZp434H2111,FLJ45829
Approved Drugs0
Drugs in Clinical Trials11
Highest Development StagePhase 2 Clinical

Product Inquiry

LRRK2 Synonyms

PARK8,Leu-rich repeat,LRR-containing protein kinase 2,Dardarin

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
BIIB-094BIIB-094; ION-859; IONIS-BIIB7RxPhase 2 ClinicalBiogen IncParkinson Disease
Details
NEU-411NEU-411Phase 2 ClinicalNeuron23 IncParkinsonian Disorders; Parkinson Disease
Details
DNL-151BIIB122; DNL151; BIIB-122; DNL-151Phase 2 ClinicalGenentech IncParkinson Disease
Details
VRN-01VRN-01Phase 1 ClinicalVoronoi IncGlioblastoma
Details
LRRK2 Kinase Inhibitors (Oncodesign/Servier)ODS-2005294Phase 1 ClinicalNeoplasms; Parkinson Disease; Central Nervous System Diseases
Details
OPM-201OPM-201; S-221237Phase 1 ClinicalOncodesign BiotechnologyParkinson Disease
Details
ARV-102ARV-102Phase 1 ClinicalArvinas IncSupranuclear Palsy, Progressive; Parkinson Disease
Details
HT-4253HT-4253Phase 1 ClinicalHalia Therapeutics IncAlzheimer Disease
Details
FB418FB418Phase 1 Clinical1st Biotherapeutics IncParkinsonian Disorders; Parkinson Disease; Amyotrophic Lateral Sclerosis
Details
WXWH0226WXWH0226; WXWH-0226Phase 1 ClinicalGuizhou Inochini Technology Co Ltd, Wuxi Apptec Co LtdParkinson Disease
Details
BT-0267BT 267; BT-0267ClinicalBrenig Therapeutics IncParkinson Disease
Details
  • Overview
  • Product Inquiry
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland